Altimmune
ALT
#8296
Rank
ยฃ0.24 B
Marketcap
ยฃ1.25
Share price
2.17%
Change (1 day)
-60.68%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2026 (TTM): -ยฃ68.73 Million

According to Altimmune's latest financial reports the company's current earnings are ยฃ0.03 Million. In 2025 the company made an earning of -ยฃ67.2 Million, an increase over its 2024 earnings that were of -ยฃ71.96 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ68.73 Million2.27%
2025 -ยฃ67.2 Million-6.61%
2024 -ยฃ71.96 Million7.48%
2023 -ยฃ66.95 Million4.17%
2022 -ยฃ64.27 Million-12.55%
2021 -ยฃ73.49 Million78.27%
2020 -ยฃ41.23 Million164.65%
2019 -ยฃ15.58 Million-54.59%
2018 -ยฃ34.31 Million-12.95%
2017 -ยฃ39.41 Million-164.04%
2016 ยฃ61.53 M-2506.1%
2015 -ยฃ2.56 Million-65.85%
2014 -ยฃ7.49 Million-15.12%
2013 -ยฃ8.83 Million146.72%
2012 -ยฃ3.58 Million-16.07%
2011 -ยฃ4.27 Million-76.1%
2010 -ยฃ17.83 Million-8.89%
2009 -ยฃ19.57 Million31.17%
2008 -ยฃ14.92 Million549.91%
2007 -ยฃ2.3 Million7.52%
2006 -ยฃ2.14 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-ยฃ0.13 Billion 73.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-ยฃ13.75 Million-80.21%๐Ÿ‡บ๐Ÿ‡ธ USA